Description
Camden Ashwagandha KSM-66® delivers 500mg of the world’s most clinically researched ashwagandha root extract in every vegan capsule. KSM-66® is a premium, trademark-protected form of Withania somnifera — developed over 14 years of dedicated research and used in more than 24 gold-standard human clinical trials, making it the benchmark choice for stress support, energy and mental clarity.
Per 1-capsule serving
- KSM-66 Ashwagandha Root Extract (standardised to >=5% withanolides) — 500mg
Key features
- 500mg KSM-66® ashwagandha root extract per capsule — the clinically studied dose
- 90 vegan capsules — a 3-month supply at one capsule daily
- Clean formula: rice bran and HPMC vegetable capsule only — no magnesium stearate, fillers or binders
- Manufactured in the UK to GMP standards
How to take: Adults, take 1-2 capsules daily with food and water.
Manufactured in the United Kingdom to GMP standards. KSM-66 Ashwagandha is a registered trademark of Ixoreal Biomed Inc.
About the ingredients
Ashwagandha (Withania somnifera)
Ashwagandha (Withania somnifera) is a small evergreen shrub in the Solanaceae family, native to India and parts of the Middle East and North Africa. It has a long history of use in traditional Ayurvedic medicine, where the root is used as a tonic and adaptogen. It is sold in the UK as a food supplement, typically as a standardised root extract. There are no authorised UK food-supplement health claims for ashwagandha; trial evidence for stress, sleep, and related outcomes is concentrated on specific branded extracts (KSM-66, Sensoril, Shoden) at specific durations. Read more in the encyclopaedia
KSM-66® Ashwagandha (Withania somnifera root extract)
KSM-66® is a specific branded form of Withania somnifera (ashwagandha) root extract, manufactured by Ixoreal Biomed (Hyderabad, India) under a patented milk-extraction process. It is the most-cited standardised ashwagandha extract in the modern human-trial literature and the branded form whose trial portfolio underpins most clinical-grade ashwagandha supplements sold in the UK. KSM-66 standardises ≥5% withanolides by HPLC and uses root-only material (no leaf). There are no UK-authorised food-supplement health claims for ashwagandha; trial framing on KSM-66 surfaces must remain descriptive. UK FSA / CoT 2024 opinion on ashwagandha raised hepatotoxicity questions — that caution applies to KSM-66 as much as to generic forms. Read more in the encyclopaedia
